TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IPSC

Century Therapeutics Inc

Healthcare · Biotechnology

1.70$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IPSC
Line item 2015 2016 2019 2020 2021 2022 2023 2024 2025
– – – – – – -728.7% – –
– – – +463.1% +167.3% +125.2% +54.5% +2.0% -1.5%
– – – +495.9% +432.2% +128.9% +37.1% -13.2% -46.1%
– – – -97.4% -21.6% +128.9% – – –
– – – +115.2% -157.5% – -92.4% -198.9% –
– -62.2% -77.9% +299.4% +357.7% -31.9% -55.1% -98.9% +450.6%
– – – +14.7% +1,211.0% -95.6% – -22.3% +126.4%
– – – – – -87.9% – – –
– – – +0.0% -100.0% – – -100.0% –
– – -23.7% -36.3% +776.0% -93.5% -135.8% – -99.8%
– – – -142.1% – -7.7% -231.5% – -68.1%
– – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?